|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 14/51 | |
| A61K 38/10 | |||
| A61K 38/17 |
| (11) | Patento numeris | 2264063 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10008795.6 |
| Europos patento paraiškos padavimo data | 2006-04-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-12-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-06-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 677583 P | 2005-05-03 | US | |
| 776847 P | 2006-02-24 | US | |
| 782244 P | 2006-03-13 | US | |
| 792645 P | 2006-04-17 | US | |
| 411003 | 2006-04-25 | US |
| (72) |
Paszty, Christopher, US
Robinson, Marty Kim, GB
Graham, Kevin, US
Henry, Alistair James, GB
Hoffmann, Kelly Sue, US
Latham, John, US
Lawson, Alastair, GB
Lu, Hsieng Sen, US
Popplewell, Andy, GB
Shen, Wenyan, US
Winkler, David, US
Winters, Aaron George, US
|
| (73) |
UCB Pharma, S.A.,
Allée de La Recherche 60, 1070 Brussels,
BE
|
| (54) | SCLEROSTIN BINDING ANTIBODY |
| SCLEROSTIN BINDING ANTIBODY |